Market Place
Sourcing Support
Longhorn Vaccines` Peptide Vaccine Targets Sepsis from TB Resistance
13 Nov 2024 //
BUSINESSWIRE
Longhorn Presents Sepsis Vaccine Data at Union World Conference
07 Nov 2024 //
BUSINESSWIRE
Longhorn Highlights Data For LHNVD-303 Vaccine At IDWeek 2024
16 Oct 2024 //
BUSINESSWIRE
Longhorn To Present Vaccine Data At IDWeek 2024
09 Oct 2024 //
BUSINESSWIRE
Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress
02 Apr 2024 //
BUSINESSWIRE
Longhorn Vaccines Presents Targeted Vaccine Approach with LHNVD-301
15 Nov 2023 //
BUSINESSWIRE
Longhorn to Present Durability Data of Universal Influenza Vaccine, LHNVD-105
03 Oct 2023 //
BUSINESSWIRE
Longhorn Vaccines Presents Data Demonstrating Activity of LHNVD-201
25 Sep 2023 //
BUSINESSWIRE
Longhorn Vaccines and Diagnostics to Present Durability Data of LHNVD-201
19 Sep 2023 //
BUSINESSWIRE
Longhorn Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year”
03 Nov 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.